Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma.

ABSTRACT:

Background

New treatment options and supportive care measures have greatly improved survival of patients with non-Hodgkin lymphoma (NHL) but may not be affordable for those with no insurance or inadequate insurance.

Methods

Using data from the Surveillance, Epidemiology, and End Results database, we estimated overall and cause-specific survival according to insurance status within 3 years after diagnosis of patients diagnosed with NHL in the U.S. in the period 2007-2011. Because NHL is a heterogeneous condition, we also examined survival in diffuse large B-cell lymphoma (DLBCL).

Results

Survival was higher for patients with non-Medicaid insurance compared with either uninsured patients or patients with Medicaid. For patients with any NHL, the 3-year survival estimates

SUBMITTER: Pulte D 

PROVIDER: S-EPMC4425386 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature